Anthem Biosciences consolidated net profit rises 21.93% in the September 2026 quarter
(04 Nov 2026)

Back
Net profit of Anthem Biosciences rose 21.93% to Rs 211.46 crore in the quarter ended September 2026 as against Rs 173.43 crore during the previous quarter ended September 2025. Sales rose 8.00% to Rs 594.03 crore in the quarter ended September 2026 as against Rs 550.03 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales594.03550.03 8
OPM %45.7039.62 -
PBDT327.08263.10 24
PBT296.37229.60 29
NP211.46173.43 22
BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew